$ Value
$0
Shares
3,549
Price
$0
Filed
May 8
Insider
Name
Bradner James E.
Title
EVP, R&D, & Chief Sci. Officer
CIK
0002005159
Roles
Transaction Details
Transaction Date
2025-05-06
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
29,753
Footnotes
The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. | These shares include 948 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. | These non-qualified stock options were granted pursuant to the Equity Incentive Plan and are exercisable in four equal annual installments of 25% each commencing on 5/6/2026.
Filing Info
Other Insiders at AMGN (90d)
No other insider activity at this issuer in the last 90 days.